farmacon-global-logo

OUR APPROACH

For over 15 years, Farmacon Global has been a leading force in accelerating clinical research and market access projects. Our mission is rooted in a commitment to bring transformative healthcare solutions to the global stage. Through strategic alliances with on-the-ground medical experts and partners, we navigate the complexities of emerging markets with precision and cultural sensitivity. Our concierge approach isn’t just a service; it’s a pledge to guide our partners through every stage of the journey. At Farmacon Global, we redefine possibilities, celebrating diversity as we work towards a healthier and more accessible future.

Expertise and Commitment to Action

With our pillars of expertise and dedication, we’ve carefully curated a network of on-the-ground medical professionals, forming alliances that are built on a shared passion for advancing healthcare.
Every clinical trial is not just a project; it’s a shared commitment.
Our concierge approach is more than a service; it’s a promise to guide you through every step of our journey together. We understand that success is not just measured by data points but by the lives touched, the communities impacted, and the transformative stories written through our collaborative efforts.

Beyond Boundaries: Navigating Emerging Markets with Precision

Farmacon Global leads with precision and cultural sensitivity. Our strategies align with the unique tapestry of the communities we serve.
Join us on a journey where every clinical trial tells a story, and diversity is not just a metric but a celebration of human experiences.
Together, we can redefine global access to healthcare, one breakthrough at a time.

Sara Tylosky, MBA
CEO

Sara Tylosky, MBA, CEO at Farmacon Global, brings over 20 years of experience leading teams in both large and small pharmaceutical and biotech environments. She has led Farmacon Global, a strategic CRO of medical consultants, in accelerating clinical trials, increasing diversity, supporting enrollment, and paving the way to market access in emerging markets.

Known for her high cultural intelligence and problem-solving skills, Sara and her team specialize in Rare Diseases, Immunology, Infectious Diseases, Cancer, and Vaccines. Fluent in Spanish and having lived on four continents, she has a special focus on Latin America while actively expanding into other key markets globally. Sara’s direction plays a pivotal role in steering Farmacon Global toward healthcare innovation and global market leadership.